Immunologically high-risk recipient strategies

This publication has 15 references indexed in Scilit:

• CLINICAL APPLICATION OF IMMUNOSUPPRESSIVE AGENTS IN RENAL TRANSPLANTATION
  Surgical Clinics of North America, 1998
• An update on new immunosuppressive drugs undergoing preclinical and clinical trials: Potential applications in organ transplantation
  American Journal of Kidney Diseases, 1997
• OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: Association with improvement in long-term survival
  Kidney International, 1996
• A RANDOMIZED CLINICAL TRIAL OF INDUCTION THERAPY WITH OKT3 IN KIDNEY TRANSPLANTATION
  Transplantation, 1993
• THE LONG-TERM EFFECTS OF PROPHYLACTIC OKT3 MONOCLONAL ANTIBODY IN CADAVER KIDNEY TRANSPLANTATION—A SINGLE-CENTER, PROSPECTIVE, RANDOMIZED STUDY
  Transplantation, 1992
• ANALYSES OF THE UNOS SCIENTIFIC RENAL TRANSPLANT REGISTRY AT THREE YEARS—EARLY EVENTS AFFECTING TRANSPLANT SUCCESS1–3
  Transplantation, 1992
• IMPROVED SURVIVAL OF PRIMARY CADAVERIC RENAL ALLOGRAFTS IN BLACKS WITH QUADRUPLE IMMUNOSUPPRESSION1
  Transplantation, 1992
• IMPROVED RESULTS USING OKT3 AS INDUCTION IMMUNOSUPPRESSION IN RENAL ALLOGRAFT RECIPIENTS WITH DELAYED GRAFT FUNCTION
  Transplantation, 1990
• SEQUENTIAL ANTILYMPHOBLAST GLOBULIN AND CYCLOSPORINE FOR RENAL TRANSPLANTATION
  Transplantation, 1987
• THE EFFECTS OF DELAYED FUNCTION OF RECIPIENTS OF CADAVER RENAL ALLOGRAFTS
  Transplantation, 1986